BUZZ-Cocrystal Pharma rises as FDA fast-tracks oral norovirus drug
Reuters04-02 20:25
BUZZ-<a href="https://laohu8.com/S/COCP">Cocrystal Pharma</a> rises as FDA fast-tracks oral norovirus drug
** Shares of drug developer Cocrystal Pharma COCP.O rise 9% to $1.10 premarket
** Co says FDA grants fast-track status to its experimental oral drug CDI-988 for norovirus, a highly contagious stomach virus that causes vomiting and diarrhea; no approved treatments exist
** CDI-988 is being tested in an early-stage study in up to 40 healthy adults to reduce norovirus symptoms and assess safety and how the drug moves through the body, co says
** Says norovirus hits immunocompromised patients hardest, often causing long-term infections; CDI-988 is not yet approved
** Fast-track status aims to speed development and review for drugs addressing serious diseases with unmet medical needs
** As of last close, stock up ~4% YTD
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments